Additionally, they discovered that the increase in serum IFN-β and the number of blood T cells following radiotherapy were highly correlated with the occurrence of the immune response, suggesting that IFN-β could predict the efficacy of the anti-tumor immune response. This evidence concerns the gene IFNB1 and neoplasm.